Episode 104: Fauci's star turn, the latest on coronavirus, and an under-the-radar Alzheimer's drug
When can we stop distancing? Does the "deep state" meet over Zoom? And could the amyloid hypothesis come through at last?
26 Mars 202028min
Episode 103: Trump's coronavirus pivot, life inside the ICU & drug development in a pandemic
Why did the U.S. change its tune on coronavirus? What's it like to be an ICU nurse right now? And when are we getting a vaccine?
19 Mars 202025min
Episode 102: Voices from the coronavirus pandemic, in Italy, New York, and the high seas
How long will this pandemic persist? Are U.S. hospitals going to be overwhelmed? And what’s it like to be quarantined on a cruise ship?
12 Mars 202025min
Episode 101: Pharma’s response to coronavirus, Google's appetite for health data, & biotech in China
Does “The Art of the Deal” cover vaccines? Is patient privacy a relic of the past? And how big can biotech get in China?
5 Mars 202028min
Episode 100: Wall Street's coronavirus freakout, clinical trial difficulties, and a look back
Is the market overreacting to the coronavirus? Why do so many clinical trials go unfilled? And how do you pronounce "Martin Shkreli"?
27 Feb 202028min
Episode 99: Genetic medicine w/ Ethan Weiss, drug industry infighting, & a microbiome review
Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug?
20 Feb 202029min
Episode 98: Les Funtleyder on biotech investing; the Zolgensma lottery & billionaire philanthropy
What's the right way to give drugs away? Is $3 billion even a lot of money? And when is biotech hype justified?
13 Feb 202024min
Episode 97: Fake outbreak news, treating coronavirus, and biotech's Mount Rushmore
Is peer review underrated? Can biotech stop an outbreak? And would you mind giving us a call? We're coming up on the 100th episode of this podcast, and we're using the occasion to actualize our long-...
6 Feb 202023min
